Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?

A Daly, H Gokmen-Ozel, Anita MacDonald, MA Preece, Peter Davies, A Chakrapani, Patrick McKiernan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background:  Tyrosinaemia type 1 (HT1) is treated with a tyrosine and phenylalanine-restricted diet, amino acids free of phenylalanine and tyrosine, and nitisinone (NTBC). Treatment guidelines recommend plasma tyrosine between 200-400 μm and phenylalanine at least >30 μm. There is little information on the diurnal variation of plasma tyrosine or phenylalanine in HT1. Low plasma phenylalanine
Original languageEnglish
JournalJournal of Human Nutrition and Dietetics
DOIs
Publication statusPublished - 15 Dec 2011

Fingerprint

Dive into the research topics of 'Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?'. Together they form a unique fingerprint.

Cite this